Home > Publications database > Acute responses of cytokines and adipokines to aerobic exercise in relapsing vs. remitting women with multiple sclerosis. > print

001     134858
005     20240229105044.0
024 7 _ |a 10.1016/j.ctcp.2018.03.004
|2 doi
024 7 _ |a pmid:29705471
|2 pmid
024 7 _ |a 1744-3881
|2 ISSN
024 7 _ |a 1873-6947
|2 ISSN
024 7 _ |a altmetric:70321815
|2 altmetric
037 _ _ |a DKFZ-2018-00648
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Majdinasab, Nastaran
|b 0
245 _ _ |a Acute responses of cytokines and adipokines to aerobic exercise in relapsing vs. remitting women with multiple sclerosis.
260 _ _ |a Edinburgh [u.a.]
|c 2018
|b Elsevier44913
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1529307951_27072
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a To examine the acute effect of exercise on cytokines and adipokines during relapse and the remitting phase of multiple sclerosis (MS).Thirty women with MS in the relapsing or remitting phase were matched with fifteen healthy controls. Participants performed a single-bout of aerobic exercise at 60-70% maximal heart rate. Furthermore, five women in the relapsing phase were enrolled (control relapse) and did not receive any intervention. Blood samples were taken before, immediately after, 1-h and 6-h after the exercise.Levels of IL-10 and TNF-α in response to exercise were similar in healthy and MS remitting subjects. Compared to baseline, TNF-α levels in relapsing subjects were significantly decreased immediately after exercise. Immediately following exercise, leptin levels significantly decreased in relapsing subjects. Adiponectin and IL-6 showed no significant difference between groups.After relapse, exercise does not induce inflammatory cytokine response and temporarily improves both cytokine and adipokine balance.
536 _ _ |a 317 - Translational cancer research (POF3-317)
|0 G:(DE-HGF)POF3-317
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Motl, Robert W
|b 1
700 1 _ |a Mokhtarzade, Motahare
|b 2
700 1 _ |a Zimmer, Philipp
|0 P:(DE-He78)d05b24af674d8ef2c455634434b67770
|b 3
|u dkfz
700 1 _ |a Ranjbar, Rouholah
|b 4
700 1 _ |a Keytsman, Charly
|b 5
700 1 _ |a Cullen, Tom
|b 6
700 1 _ |a Negaresh, Raoof
|b 7
700 1 _ |a Baker, Julien S
|b 8
773 _ _ |a 10.1016/j.ctcp.2018.03.004
|g Vol. 31, p. 295 - 301
|0 PERI:(DE-600)2181895-2
|p 295 - 301
|t Complementary therapies in clinical practice
|v 31
|y 2018
|x 1744-3881
909 C O |o oai:inrepo02.dkfz.de:134858
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)d05b24af674d8ef2c455634434b67770
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-317
|2 G:(DE-HGF)POF3-300
|v Translational cancer research
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b COMPLEMENT THER CLIN : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)G210-20160331
|k G210
|l Bewegung, Präventionsforschung und Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G210-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21